<DOC>
	<DOCNO>NCT01778335</DOCNO>
	<brief_summary>The purpose study understand whether new treatment stroke - endovascular clot removal - add current standard care improve patient outcome . All patient receive best standard stroke treatment . This include treat patient clot dissolve drug tPA ( tissue plasminogen activator ) . However , t-PA work patient others eligible receive t-PA present late treatment ( woke stroke symptom stroke witness ) . During endovascular revascularization blockage artery remove use device call stentreivers give clot dissolve drug site blockage artery restore blood flow . Stentrievers device design different company remove blood clot artery . Up maximum 500 people 20-25 hospital across Canada country participate study .</brief_summary>
	<brief_title>Endovascular Treatment Small Core Proximal Occlusion Ischemic Stroke</brief_title>
	<detailed_description>ESCAPE phase 3 , randomize , open-label blind outcome evaluation , control , parallel group design . The primary objective study show rapid endovascular revascularization amongst radiologically select ( small core/proximal occlusion ) patient ischemic stroke result improve outcome compare patient treat clinical routine . Eligible patient enrol within 12 hour last see normal baseline NIHSS &gt; 5 time randomization . There must confirm symptomatic intracranial occlusion , base single phase , multiphase dynamic CTA , one follow location : Carotid T/L , M1 MCA , M1-MCA equivalent ( 2 M2-MCAs ) . Anterior temporal artery consider M2 . All patient receive best standard medical care accord modern acute stroke care guideline . Control arm subject receive best medical care . In intervention/experimental arm , subject treat endovascular thrombectomy thrombolysis use currently available technology use ESCAPE site thrombectomy/thrombolysis . This study consist one 90-day study period subject . Subjects hospitalize care acute stroke accord current standard care . Subjects require return clinic Days 30 &amp; 90 end-of-study procedure .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Inclusion Criteria A . Clinical ( Heterogeneous sample frame ) 1 . Acute ischemic stroke 2 . Age 18 great 3 . Onset ( lastseenwell ) time randomization time &lt; 12 hour . 4 . Disabling stroke define baseline NIHSS &gt; 5 time randomization . 5 . Prestroke ( 24 hour prior stroke onset ) independent functional status activity daily live modify Barthel Index &gt; 90 . Patient must live home , apartment senior lodge nurse care require . B . Imaging ( Homogeneous target population ) 6 . Confirmed symptomatic intracranial occlusion , base single phase , multiphase dynamic CTA , one follow location : Carotid T/L , M1 MCA , M1MCA equivalent ( 2 M2MCAs ) . Anterior temporal artery consider M2 . 7 . Noncontrast CT CTA trial eligibility perform repeated ESCAPE stroke center endovascular suite onsite . 8 . Endovascular treatment intend initiate ( groin puncture ) within 60 minute baseline noncontrast CT target baseline noncontrast CT first recanalization 90 minute . 9 . Signed informed consent appropriate sign deferral consent approve . Exclusion Criteria 1 . Baseline noncontrast CT reveals moderate/large core define extensive early ischemic change ASPECTS 05 territory symptomatic intracranial occlusion . 2 . Other confirmation moderate large core define one three way : 1 . On single phase , multiphase dynamic CTA : minimal collateral region great 50 % MCA territory compare pial fill contralateral side ( multiphase/dynamic CTA prefer ) OR 2 . On CT perfusion ( &gt; 8 cm coverage ) : low CBV low CBF ASPECTS &lt; 6 AND symptomatic MCA territory OR 3 . On CT perfusion ( &lt; 8 cm coverage ) : region low CBV low CBF &gt; 1/3 CTP image symptomatic MCA territory . 3 . Groin puncture possible within 60 minute first slice noncontrast CT acquisition ( please note CTP perform do CTA ) . 4 . No femoral pulse difficult endovascular access result noncontrast CTtorecanalization time longer 90 minute , result inability deliver endovascular therapy . 5 . Pregnancy ; woman childbearing potential urine serum beta HCG test positive . 6 . Severe contrast allergy absolute contraindication iodinate contrast . 7 . Suspected intracranial dissection cause stroke . 8 . Clinical history , past image clinical judgment suggest intracranial occlusion chronic . 9 . Patient severe fatal comorbid illness prevent improvement followup render procedure unlikely benefit patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>recanalization</keyword>
	<keyword>endovascular</keyword>
	<keyword>thrombectomy</keyword>
</DOC>